Business / Finance

RSS

Metrion Biosciences announces closure of funding round

Metrion Biosciences Ltd, the specialist ion channel contract research and drug discovery company, announced today that it has completed a fully subscribed funding round on 14 March.

From Metrion Biosciences Limited 2 Apr 2019

Quanterix appoints Amol Chaubal as Chief Financial Officer

Quanterix announced that it has named Amol Chaubal to the position of Chief Financial Officer, effective April 12, 2019.

From Quanterix 28 Mar 2019

IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019

IONTAS Limited, a leader in the discovery and optimization of fully human antibodies, has won ‘Small Business of the Year’ category at the Cambridge News Business Excellence Awards 2019.

25 Mar 2019

Quanterix corporation releases operating results for fourth quarter and full year 2018

Quanterix announced financial results for the three months and twelve months ended Dec. 31, 2018.

From Quanterix 7 Mar 2019

Gottleib resigns from FDA – issue of rising teen vaping remains unsolved

Scott Gottlieb, the commissioner of the United States Food and Drug Administration (FDA) has announced that he would resign from office at the end of this month.

5 Mar 2019

MD&M West 2019: Medical Devices, 3D Printing and Staying Compliant

Between February 5 - 7 2019, the Anaheim Convention Center in Southern California hosted the annual MD&M West medical manufacturing conference.

27 Feb 2019

Quanterix to release fourth quarter and full year 2018 financial results and host conference call on Thursday, March 7, 2019

Quanterix announced that it will release its financial results for fourth quarter and full year 2018 after the close of trading on Thursday, March 7, 2019.

From Quanterix 26 Feb 2019

NICE renews accreditation for Advanced

The National Institute for Health and Care Excellence (NICE) has recognized Advanced for demonstrating high standards in producing healthcare guidance.

18 Feb 2019

Sphere Fluidics announces closure of $2 million (circa £1.5 million) investment round

Sphere Fluidics announced today that is has closed a $2 million (circa £1.5 million) investment round.

From Society for Laboratory Automation and Screening (SLAS) 30 Jan 2019

QPS launches new brand identity to support continued global expansion

The year 2019 marks 24 years of growth for QPS, LLC, a leading global CRO focused on bioanalytics and clinical trials that accelerate pharmaceutical breakthroughs.

16 Jan 2019

Clinigen, Accord Healthcare extend exclusive European clinical trial supply agreement

Clinigen Group plc, the global pharmaceutical and services company, announces that its Clinical Trial Service business has extended its exclusive European clinical trial supply agreement with Accord Healthcare. Clinigen is also offering pharma companies an ‘on demand’ service to Accord’s products, a first for the industry.

From Clinigen Group 11 Jan 2019

Excelitas acquires Axsun Technologies

Excelitas Technologies Corp., a global technology leader focused on delivering innovative, customized photonic solutions, has completed the acquisition of Axsun Technologies.

From Excelitas Technologies 3 Jan 2019

ZEISS achieves record-breaking revenue and earnings

The ZEISS Group is continuing its growth trajectory: Revenue increased by nine percent to EUR 5.817 billion (previous year: EUR 5.348 billion).

From Carl Zeiss AG 19 Dec 2018

Butantan Institute signs collaboration agreement with MSD to develop dengue vaccines

On Wednesday, December 12, 2018, Brazil's Butantan Institute signed a collaboration agreement with Merck Sharp & Dohme (MSD) to develop dengue vaccines.

12 Dec 2018

New collaborative partnership in quest of novel antibiotics

The Global Antibiotic Research and Development Partnership, Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.

12 Dec 2018

Subsidiaries of Community Health Systems sign definitive agreement to sell four South Carolina hospitals

Community Health Systems, Inc. announced today that subsidiaries of the Company have signed a definitive agreement to sell four South Carolina hospitals - 82-bed Chester Regional Medical Center in Chester, 225-bed Springs Memorial Hospital in Lancaster, 396-bed Carolinas Hospital System in Florence, and 124-bed Carolinas Hospital System - Marion in Mullins - along with related businesses, including physician clinic operations and outpatient services, to the Medical University Hospital Authority in Charleston, S.C.

20 Nov 2018

Nicoya designate the Institute for Stem Cell Biology and Regenerative Medicine as the OpenSPR Centre of Excellence

Currently in India, there are over 200,000 researchers working on numerous applications to better understand diseases and advance drug discovery. To support their discoveries, we are thrilled to announce the opening of the OpenSPR Centre of Excellence in Bangalore, India!

From Nicoya Lifesciences 15 Nov 2018

Empowering the NHS through Industry Partnerships

An interview with Cara Afzal and Lee-Ann Farrell discussing the importance of industry partnerships with the NHS, and how Janssen are working to improve dementia care for Manchester and hematology services for Wales.

13 Nov 2018

Illumina signs agreement to acquire Pacific Biosciences

Illumina, Inc. and Pacific Biosciences today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction.

2 Nov 2018

RTI Surgical enters into definitive agreement to acquire Paradigm Spine

RTI Surgical, Inc., a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments.